Gustav Orell

Mr. Gustav Orell

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2025 in Neurogastroenterology & Motility
Verified
Journal Article
Open access
TBTetyana Bureychak
Tetyana Bureychak
JSJenny Sjödahl
Jenny Sjödahl
NBNawroz Barazanji
Nawroz Barazanji
GOGustav Orell
Gustav Orell
OBOlivia Book
Olivia Book
SWSusanna A. Walter
Susanna A. Walter
Background: The connection between childhood trauma and irritable bowel syndrome (IBS) is well documented. However, knowledge regarding distinct associations between different subtypes of childhood trauma and both intestinal and extraintestinal symptoms is widely lacking. The current cross‐sectional study aimed to elucidate the impact of different types of childhood trauma on IBS symptomatology. Methods: In 169 women with moderate to severe IBS and 39 healthy women (HCs), childhood trauma was assessed using the Childhood Trauma Questionnaire. Gastrointestinal, extraintestinal, and psychological symptoms were evaluated via symptom diaries and questionnaires. Key Results: The overall prevalence of childhood trauma was significantly higher in women with IBS compared to HCs, with odds ratio (OR) 3.41 (95% CI, 1.35–8.60, p = 0.009) and with the highest rates observed for emotional and sexual abuse. Overall childhood trauma was positively associated with symptom severity ( r = 0.305, p = 0.016). Among trauma types, emotional abuse was the strongest predictor of IBS, with a 6‐fold increased odds of disorder, OR 6.69 (95% CI, 1.97–22.68, p = 0.002). Women with IBS and a history of emotional abuse reported longer episodes of abdominal pain, more defecation urgency, and higher levels of anxiety and depression. Conclusions: Our findings support the significant role of childhood trauma in IBS pathology and increased symptom burden. They further indicate the specific relevance of emotional abuse influencing not only gastrointestinal symptoms but also extraintestinal and psychological complaints. These findings may help contribute to the identification of a distinct phenotype of IBS patients with a history of traumatic emotional abuse during childhood.

22 October 2026 in Journal of Patient Experience
Verified
Journal Article
Open access
JGJulia Gustavsson
Julia Gustavsson
JSJenny Sjödahl
Jenny Sjödahl
GOGustav Orell
Gustav Orell
NBNawroz Barazanji
Nawroz Barazanji
AIAnna Ingemansson
Anna Ingemansson
KPKatarina Pihl-Lesnovska
Katarina Pihl-Lesnovska
Irritable bowel syndrome (IBS) is a disorder of gut-brain interaction with a prevalence of approximately 4% adults. The characteristic symptoms are abdominal pain and bowel dysfunction. For severe IBS, an individualized multidisciplinary approach is recommended, including dietary, psychological and pharmacological treatment, as well as physiotherapy and education. Treatment can be challenging, partly because its success depends on lifestyle changes. The aim was to describe patients’ experiences of person-centered multidisciplinary treatment for IBS. Thirteen patients who had participated in person-centered multidisciplinary treatment for IBS were interviewed. A semi-structured interview guide was used. Data was analyzed using qualitative content analysis with an inductive approach. Analysis of the participants’ experiences person-centered resulted in two categories: (1) Transfer of knowledge, including two subcategories, and (2) Interaction and dialogue, including four subcategories. The caregiver’s role as support, guide and expert, as well as the importance of increased patient knowledge and understanding of IBS highlighted. The findings indicate that participation influence over one’s care is essential and may affect treatment adherence. Patients suggested that this type of treatment could benefit all individuals with IBS.

29 September 2026 in Cells
Verified
Journal Article
Open access
PDF file
JBJulie Beaudeau
Julie Beaudeau
CECelia Escudero-Hernández
Celia Escudero-Hernández
VAVittorio Abruzzese
Vittorio Abruzzese
GKGeorgios Katinios
Georgios Katinios
GOGustav Orell
Gustav Orell
ÅKÅsa V Keita
Åsa V Keita
Microscopic colitis (MC) is an inflammatory bowel disease characterized by chronic watery diarrhea. Although barrier dysfunction and immune activation are implicated, underlying mechanisms remain unclear. The aim of this study was to characterize enteric glial cells (EGC) and mast cell distribution across MC subtypes, assess treatment effects, and explore EGC-related gene expression and barrier markers. Colonic biopsies from patients with active collagenous colitis (aCC), budesonide-refractory CC (rCC), and active lymphocytic colitis (LC) were compared to irritable bowel syndrome (IBS), ulcerative colitis (UC), and healthy controls (HC). A subset of CC patients was studied during active disease (aCC) and in clinical remission due to budesonide treatment (tCC). Immunofluorescence quantified EGC positive for glial fibrillary acidic protein (EGCGFAP+) and S100 calcium-binding protein B (EGCS100β+), mast cell tryptase, and tight junction proteins. RNA-sequencing assessed EGC-related gene expression. Results showed that EGCGFAP+ were highest in rCC and decreased following budesonide treatment in aCC, whereas EGCS100β+ were highest in aCC, remained unchanged following treatment, resembled IBS, and were reduced compared with UC. Mast cell numbers were higher in aCC than in HC and rCC but remained unchanged following treatment, while mast cell degranulation decreased after treatment. Tight junction proteins were unchanged. RNA-sequencing indicated differential regulation of EGC-related genes. In conclusion, MC shows subtype-specific alterations involving EGC and mast cells, suggesting distinct glial states and differential treatment responsiveness. Our findings support the presence of distinct neuroimmune alterations in CC and LC and highlight EGC as potential contributors to MC pathophysiology.